Clinical Trial Update: Study in Healthy Subjects, Patients With Urea Cycle Disorders (UCD) and Carriers of UCD Mutations to Evaluate Urea Cycle Function [NA]

View source ↗

Summary

A completed clinical trial by Cytonet assessing urea cycle function in healthy subjects, patients with urea cycle disorders, and carriers of UCD mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorders

Snippet

Sponsor: Cytonet GmbH & Co. KG | Conditions: Urea Cycle Disorders | NA | Status: COMPLETED